Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-alpha in Pacing-Induced Heart Failure

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Circulation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs.

  2002cited by this paper
• Partial fatty acid oxidation inhibitors: a potentially new class of drugs for heart failure

  2002cited by this paper
• Metabolic Gene Expression in Fetal and Failing Human Heart

  2001cited by this paper
• Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart.

  2001cited by this paper
• Increased Expression of Peroxisome Proliferator-Activated Receptor-&agr; and -&ggr; in Blood Vessels of Spontaneously Hypertensive Rats

  2001cited by this paper
• Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart*

  2001cited by this paper
• Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation.

  2001cited by this paper
• An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.

  2001cited by this paper
• Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.

  2000cited by this paper
• Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity*

  2000cited by this paper
• Peroxisome proliferator‐activated receptors in the cardiovascular system

  2000cited by this paper
• Nitric oxide controls cardiac substrate utilization in the conscious dog.

  1999cited by this paper
• Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure.

  1998cited by this paper
• Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog.

  1998cited by this paper
• Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor α*

  1998cited by this paper
• Energy deprivation and a deficiency in downstream metabolic target genes during the onset of embryonic heart failure in RXRalpha-/- embryos.

  1998cited by this paper
• A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program.

  1997cited by this paper
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate.

  1996cited by this paper
• Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.

  1996cited by this paper
• Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography.

  1995cited by this paper
• Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice.

  1995cited by this paper
• Total-body and myocardial substrate oxidation in congestive heart failure.

  1994cited by this paper
• Regulation of fatty acid oxidation in the mammalian heart in health and disease.

  1994cited by this paper
• Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation.

  1993cited by this paper
• Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.

  1993cited by this paper
• Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart.

  1993cited by this paper
• Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake.

  1992cited by this paper
• Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

  1992cited by this paper
• Defective lipid metabolism in the failing heart.

  1968cited by this paper
• MYOCARDIAL METABOLISM IN CONGESTIVE HEART FAILURE

  1951cited by this paper

• The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC

  2025cites this paper
• Inflammation and Mitochondrial Dysfunction in Cirrhotic Cardiomyopathy: Therapeutic Implications

  2025cites this paper
• Characterization of ferroptosis-triggered pyroptotic signaling in heart failure

  2024cites this paper
• SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts

  2024cites this paper
• Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy

  2023cites this paper
• Relationship between disorders of the intestinal microbiota and heart failure in infants with congenital heart disease

  2023cites this paper
• Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure

  2023cites this paper
• Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets

  2023cites this paper
• Myocardial Metabolic Reprogramming in HFpEF

  2023influential citation
• Comprehensive Analysis of Mitochondrial Dynamics Alterations in Heart Diseases

  2023cites this paper
• Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges

  2023influential citation
• SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism

  2023cites this paper
• Retained Metabolic Flexibility of the Failing Human Heart

  2023cites this paper
• From Energy Metabolic Change to Precision Therapy: a Holistic View of Energy Metabolism in Heart Failure

  2023cites this paper
• Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later

  2023cites this paper
• Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure

  2022cites this paper
• Reactivation of PPARα alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy

  2022cites this paper
• Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics

  2022cites this paper
• Narrative review of metabolomics in cardiovascular disease

  2021cites this paper
• Cardiac retinoic acid levels decline in heart failure

  2021cites this paper
• Cardiac Energy Metabolism in Heart Failure

  2021cites this paper
• Shenqi Lixin Decoction improves cardiac function in rats with adriamycin-induced heart failure through modulation of PGC-1α and mitochondrial apoptosis pathway

  2021cites this paper
• Molecular signaling pathways in right ventricular impairment of adult patients after tetralogy of Fallot repair.

  2021cites this paper
• Mitochondrial Bioenergetics and Dynamism in the Failing Heart

  2021cites this paper
• Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure

  2021cites this paper
• Heart Failure Syndrome With Preserved Ejection Fraction Is a Metabolic Cluster of Non-resolving Inflammation in Obesity

  2021cites this paper
• Untangling the Cooperative Role of Nuclear Receptors in Cardiovascular Physiology and Disease

  2021influential citation
• Cardiomyocyte peroxisome proliferator-activated receptor α is essential for energy metabolism and extracellular matrix homeostasis during pressure overload-induced cardiac remodeling

  2021cites this paper
• The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It’s Not All Bad

  2021cites this paper
• Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy

  2020cites this paper
• Irisin: linking metabolism with heart failure.

  2020cites this paper
• Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial

  2020cites this paper
• What fuels the failing heart ?

  2019cites this paper
• Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts

  2019cites this paper
• Novel Concepts in Cardiac Energy Metabolism: From Biology to Disease

  2019cites this paper
• Myocardial triglycerides in cardiac amyloidosis assessed by proton cardiovascular magnetic resonance spectroscopy

  2019cites this paper
• A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics

  2019influential citation
• GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy

  2019cites this paper
• Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop

  2019cites this paper
• Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection

  2019cites this paper
• Metabolic Profiling of Aortic Stenosis and Hypertrophic Cardiomyopathy Identifies Mechanistic Contrasts in Substrate Utilisation

  2019cites this paper
• Immunometabolic cross-talk in the inflamed heart

  2019cites this paper
• Cardiac Resynchronisation Therapy and Cellular Bioenergetics: Effects Beyond Chamber Mechanics

  2019cites this paper
• The Effect of Exercise Training on Myocardial and Skeletal Muscle Metabolism by MR Spectroscopy in Rats with Heart Failure

  2019cites this paper
• Hyperpolarised magnetic resonance for in vivo real-time metabolic imaging

  2018cites this paper
• MicroRNA-195 Regulates Metabolism in Failing Myocardium Via Alterations in Sirtuin 3 Expression and Mitochondrial Protein Acetylation

  2018cites this paper
• Retinoid X receptor alpha is a spatiotemporally-specific therapeutic target for doxorubicin-induced cardiomyopathy in adult zebrafish

  2018cites this paper
• Metabolic remodelling in heart failure

  2018cites this paper
• Handzlik, Michal and Constantin-Teodosiu, Dumitru and Greenhaff, Paul L. and Cole, Mark (2018) Increasing cardiac pyruvate dehydrogenase flux during chronic hypoxia

  2018cites this paper
• Endoplasmic reticulum stress induces cardiac dysfunction through architectural modifications and alteration of mitochondrial function in cardiomyocytes

  2018cites this paper
• Modulations of Keap1‐Nrf2 signaling axis by TIIA ameliorated the oxidative stress‐induced myocardial apoptosis

  2018cites this paper
• Role of microRNA in metabolic shift during heart failure.

  2017cites this paper
• Mitochondrial dysfunction and its impact on diabetic heart.

  2017cites this paper
• Metabolic profiling in experimental autoimmune myocarditis (EAM) in a rodent model using ex-vivo proton magic angle spinning magnetic resonance spectroscopy (1H-MAS-MRS) to detect myocardial injury

  2017cites this paper
• A systems genetics approach identifies Trp53inp2 as a link between cardiomyocyte glucose utilization and hypertrophic response.

  2017cites this paper
• Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.

  2016cites this paper
• Arrhythmogenic and metabolic remodelling of failing human heart

  2016cites this paper
• Animal models of Takotsubo syndrome: a multi-level experimental approach

  2016cites this paper
• Sex-related differences in the associations between plasma free fatty acid levels and clinical features in patients with hypertrophic cardiomyopathy

  2016cites this paper
• LIN28/let-7 Axis as a Regulator of Myocardial Ischemic Injury

  2016cites this paper
• Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.

  2016cites this paper
• Loss of long‐chain acyl‐CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation

  2015cites this paper
• Pathophysiology of takotsubo syndrome: temporal phases of cardiovascular responses to extreme stress.

  2014cites this paper
• Heart Failure and Loss of Metabolic Control

  2014cites this paper
• Rôle de la sirtuine 1 dans la modulation de la réponse des cardiomyocytes au stress RE et à l’apoptose

  2014cites this paper
• Beneficial effects of acute inhibition of the oxidative pentose phosphate

  2014influential citation
• Cardiac mitochondrial proteome dynamics with heavy water reveals stable rate of mitochondrial protein synthesis in heart failure despite decline in mitochondrial oxidative capacity.

  2014cites this paper
• The Implications of Altered Cholinergic Signaling in Cardiac Health and Disease

  2014cites this paper
• Cardiac Energetic Impairment in Heart Disease and the Potential Role of Metabolic Modulators: A Review for Clinicians

  2014cites this paper
• THE EFFECTS OF A NOVEL ENDOTHELIN RECEPTOR ANTAGONIST, MACITENTAN, ON RIGHT VENTRICULAR SUBSTRATE UTILIZATION AND FUNCTION IN A SUGEN5416/HYPOXIA RAT MODEL OF SEVERE PULMONARY ARTERY HYPERTENSION

  2014cites this paper
• The Gut Hormone Ghrelin Partially Reverses Energy Substrate Metabolic Alterations in the Failing Heart

  2014cites this paper
• Nanoscale three-dimensional imaging of the human myocyte.

  2014cites this paper
• Expression of lipogenic genes is upregulated in the heart with exercise training-induced but not pressure overload-induced left ventricular hypertrophy.

  2013cites this paper
• Persistent Overexpression of Phosphoglycerate Mutase, a Glycolytic Enzyme, Modifies Energy Metabolism and Reduces Stress Resistance of Heart in Mice

  2013cites this paper
• Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production

  2013cites this paper
• Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.

  2013cites this paper
• Alterations in mitochondrial function in cardiac hypertrophy and heart failure

  2013cites this paper
• Pyridine nucleotide regulation of cardiac intermediary metabolism.

  2012cites this paper
• CardioNet: A human metabolic network suited for the study of cardiomyocyte metabolism

  2012cites this paper
• Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice.

  2012cites this paper
• Frequency-selective Methods for Hyperpolarized 13C Cardiac Magnetic Resonance Imaging

  2012influential citation
• Pyridine Nucleotide Regulation of Cardiac Intermediary Metabolism Sirtuins and Pyridine Nucleotides Regulation of Ion Channels by Pyridine Nucleotides The Role of NADPH in Antioxidant Scavenging

  2012cites this paper
• Doxorubicin increases oxidative metabolism in HL-1 cardiomyocytes as shown by 13C metabolic flux analysis.

  2012cites this paper
• Micro-RNA-195 and -451 Regulate the LKB1/AMPK Signaling Axis by Targeting MO25

  2012cites this paper
• The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.

  2012cites this paper
• Myocardial substrate metabolism in heart disease.

  2012cites this paper
• Regulación de la dinámica mitocondrial del cardiomiocito por igf-1 y norepinefrina

  2012cites this paper
• Hyperpolarized 13C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart

  2012cites this paper
• High Glucose‐induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling

  2012cites this paper
• Rôle de PGC-1α dans le système cardiovasculaire : recherche d’activateurs cœur-spécifiques et étude de ses mécanismes de régulation dans le muscle lisse aortique

  2012cites this paper
• Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes.

  2012cites this paper
• Acute vagal stimulation attenuates cardiac metabolic response to β‐adrenergic stress

  2012cites this paper
• Effects of performance-enhancing drugs on cardiac structure and energy metabolism

  2012cites this paper
• Physiological versus pathological left ventricular hypertrophy

  2012cites this paper
• 5′-AMP Activated Protein Kinase is Involved in the Regulation of Myocardial β-Oxidative Capacity in Mice

  2012cites this paper
• Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS

  2011cites this paper
• Metabolic remodelling in human heart failure.

  2011cites this paper
• Modulating fatty acid oxidation in heart failure.

  2011influential citation
• Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

  2011cites this paper
• Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.

  2011cites this paper